Cargando…
Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes
BACKGROUND: The COVID-19 pandemic triggered the deployment of unfamiliar measures to safeguard successful allogeneic hematopoietic cell transplantation (allo-HCT). Among these measures, cryopreservation offered logistical benefits that could outlast the pandemic, including graft availability and tim...
Autores principales: | Keyzner, Alla, Azzi, Jacques, Jakubowski, Rita, Sinitsyn, Yelena, Tindle, Sharon, Shpontak, Svitlana, Kwon, Deukwoo, Isola, Luis, Iancu-Rubin, Camelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121136/ https://www.ncbi.nlm.nih.gov/pubmed/37210273 http://dx.doi.org/10.1016/j.transproceed.2023.03.070 |
Ejemplares similares
-
Cryopreservation of allogeneic stem cell collections during covid-19 pandemic: Products characterization and engraftment outcome
por: Keyzner, A., et al.
Publicado: (2021) -
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021) -
Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
por: Ibrahim, Uroosa, et al.
Publicado: (2021) -
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023) -
Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment
por: Fricke, Stephan, et al.
Publicado: (2009)